ReviewCancers2025

Evaluating Tumour Mutational Burden as a Key Biomarker in Personalized Cancer Immunotherapy: A Pan-Cancer Systematic Review.

Anca Zgura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.